+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
La Merie Publishing Logo

La Merie Publishing

74 products published

La Merie Publishing

74 products published

La Merie Publishing is an independent business information provider for the biotechnology and pharmaceutical industry. La Merie publish reports, offer R&D database access, and prepare tailor-made custom reports on a fee-for-service basis.

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from an Industry Perspective - Product Thumbnail Image

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from an Industry Perspective

  • Report
  • July 2021
  • 259 Pages
From
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners From an Industry Perspective - Product Thumbnail Image

Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners From an Industry Perspective

  • Report
  • May 2020
  • 195 Pages
From
Report Package: “Drug the Undruggable” Technologies - Product Thumbnail Image

Report Package: “Drug the Undruggable” Technologies

  • Report
  • May 2020
From
RNA-Targeted Small Molecules 2019: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective - Product Thumbnail Image

RNA-Targeted Small Molecules 2019: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective

  • Report
  • September 2019
  • 223 Pages
From
Competitor Analysis: KRAS Inhibitors - Product Thumbnail Image

Competitor Analysis: KRAS Inhibitors

  • Report
  • October 2019
  • 35 Pages
From
Competitor Analysis: TGF-beta/Receptor Inhibitors - Product Thumbnail Image

Competitor Analysis: TGF-beta/Receptor Inhibitors

  • Report
  • September 2019
  • 59 Pages
From
Competitor Analysis: RORgamma Antagonists and Agonists - Product Thumbnail Image

Competitor Analysis: RORgamma Antagonists and Agonists

  • Report
  • September 2019
  • 28 Pages
From
DNA Vaccines for Cancer, Infectious & Other Diseases: A Competitor Analysis - Product Thumbnail Image

DNA Vaccines for Cancer, Infectious & Other Diseases: A Competitor Analysis

  • Report
  • January 2019
  • 72 Pages
From
T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis - Product Thumbnail Image

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis

  • Report
  • June 2019
  • 463 Pages
From
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases - Product Thumbnail Image

Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases

  • Report
  • June 2019
  • 121 Pages
From
Report Package: Bispecific Antibodies - Product Thumbnail Image

Report Package: Bispecific Antibodies

  • Report
  • July 2019
From
TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals - Product Thumbnail Image

TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals

  • Report
  • May 2018
  • 294 Pages
From
Competitor Analysis: CDK9 and Mcl-1 Inhibitors - Product Thumbnail Image

Competitor Analysis: CDK9 and Mcl-1 Inhibitors

  • Report
  • March 2018
  • 26 Pages
From
Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins - Product Thumbnail Image

Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins

  • Report
  • March 2018
  • 53 Pages
From
Report Package: TCR-Based Antibody and T-Cell Immunotherapy - Product Thumbnail Image

Report Package: TCR-Based Antibody and T-Cell Immunotherapy

  • Report
  • May 2018
  • 546 Pages
From
Competitor Analysis: Survivin-Targeted Immunotherapy - Product Thumbnail Image

Competitor Analysis: Survivin-Targeted Immunotherapy

  • Report
  • May 2018
  • 28 Pages
From
Competitor Analysis: PRAME-Targeted Immunotherapy - Product Thumbnail Image

Competitor Analysis: PRAME-Targeted Immunotherapy

  • Report
  • June 2018
  • 23 Pages
From
Competitor Analysis: WT1-Targeted Immunotherapy - Product Thumbnail Image

Competitor Analysis: WT1-Targeted Immunotherapy

  • Report
  • June 2018
  • 52 Pages
From
Competitor Analysis: hTERT-Targeted Immunotherapy - Product Thumbnail Image

Competitor Analysis: hTERT-Targeted Immunotherapy

  • Report
  • June 2018
  • 20 Pages
From
Competitor Analysis: NY-ESO-1-Targeted Immunotherapy - Product Thumbnail Image

Competitor Analysis: NY-ESO-1-Targeted Immunotherapy

  • Report
  • June 2018
  • 72 Pages
From
Loading Indicator
adroll